1
100
Helvetica Chimica Acta – Vol. 95 (2012)
Daisogel ODS-AP, MeOH/H O 1:9 ! 5 :5) afforded 1 (9 mg), 2 (89 mg), 3 (53 mg), 4 (110 mg), and 9
2
(
152 mg) from Frs. 3 (9.5 g) and 4 (3.1 g). CC (MCI gel CHP20P, MeOH/H O 0 :1 ! 5 :5, then SiO ,
2
2
AcOEt/MeOH/H O 15 :1:0.5) gave 8 (88 mg) from Fr. 1 (8.2 g). CC (MCI gel CHP20P, MeOH/H O
2
2
0
:1 ! 4 :6) gave 7 (8.8 g) from Fr. 2 (10.3 g). The AcOEt fraction (85 g) was subjected to CC (SiO ,
2
CHCl /MeOH 100 :1 ! 9 :1): Fractions 5 – 10. Further CC (MCI gel CHP20P, MeOH/H O 4 :6 ! 9 :1)
3
2
afforded 5 (820 mg) and 6 (491 mg) from Fr. 9 (5.8 g). CC (SiO , petroleum/AcOEt 9 :1 ! 6 :4, then
2
Daisogel ODS-AP, MeOH/H O 7:3 ! 1:0) gave 10 (76 mg), 11 (41 mg), and 12 (62 mg) from Fr. 7
2
(
9.8 g). Compounds 13 (490 mg) and 14 (630 mg) were obtained from Fr. 5 (7.7 g) by CC (SiO ,
2
petroleum/AcOEt 100 :1 ! 25 :1) and recrystallization in CHCl /MeOH 1:1.
3
4
’’-O-b-d-Glucosyl-6’-O-(4-O-b-d-glucosylcaffeoyl)linearoside (¼(1S,4aS,6S,7R,7aS)-1-{{6-O-{(2E)-
3
-[4-(b-d-Glucopyranosyloxy)-3-hydroxyphenyl]-1-oxoprop-2-en-1-yl}-b-d-glucopyranosyl}oxy}-6-
{
{(2E)-3-[4-(b-d-glucopyranosyloxy)phenyl]-1-oxoprop-2-en-1-yl}oxy}-1,4a,5,6,7,7a-hexahydro-7-meth-
25
ylcyclopenta[c]pyran-4-carboxylic acid; 1): White amorphous powder. [a] ¼ ꢀ67.0 (c ¼ 0.12, MeOH).
D
1
UV (MeOH): 289 (4.60), 204 (4.59), 192 (4.35). IR (KBr): 3404, 1693, 1637, 1605, 1509, 1074, 621. H-
13
ꢀ
ꢀ
55 25
and C-NMR: Table 1. HR-ESI-MS: 1007.3023 ([M ꢀ H] , C H O ; calc. 1007.3032).
46
6
’-O-Acetylsweroside (¼(4aS,5R,6S)-6-[(6-O-Acetyl-b-d-glucopyranoysl)oxy]-5-ethenyl-4,4a,5,6-
25
tetrahydro-1H,3H-pyrano[3,4-c]pyran-1-one; 2): White amorphous powder. [a]
D
¼ ꢀ225.5 (c ¼ 0.11,
1
MeOH). UV (MeOH): 241 (4.06), 203 (4.00). IR (KBr): 3413, 1739, 1693, 1617, 1268, 1075. H- and
13
þ
þ
C-NMR: Table 2. HR-ESI-MS: 423.1270 ([M þ Na] , C H O Na ; calc. 423.1267).
18
24 10
6
’-O-Acetyl-3’-O-[3-(b-d-glucopyranosyloxy)-2-hydroxybenzoyl]sweroside (¼(4aS,5R,6S)-6-{{6-O-
Acetyl-3-O-[3-(b-d-glucopyranosyloxy)-2-hydroxybenzoyl]-b-d-glucopyranosyl}oxy}-5-ethenyl-4,4a,5,6-
2
5
tetrahydro-1H,3H-pyrano[3,4-c]pyran-1-one; 3): White amorphous powder. [a] ¼ ꢀ142.0 (c ¼ 0.10,
D
1
MeOH). UV (MeOH): 245 (4.23), 208 (4.58). IR (KBr): 3421, 1684, 1617, 1251, 1073, 592. H- and
13
þ
þ
C-NMR: Table 2. HR-ESI-MS: 721.1976 ([M þ Na] , C H O Na ; calc. 721.1956).
31
38 18
Acidic Hydrolysis of Compounds 1 – 3. A soln. of 1, 2 or 3 (each 2 – 3 mg) in 3m aq. CF COOH (3 ml)
3
was heated for 2 h at 1208. Then, the mixture was cooled and concentrated. To this hydrolyzate were
added the following solns.: (2S)-1-aminopropan-2-ol/anh. MeOH 1:8 (20 ml), AcOH/anh. MeOH 1:4
(
17 ml), and 3% NaBH CN in anh. MeOH (17 ml). The mixture was allowed to react for 2 h at 658. After
3
3
cooling, 3m aq. CF COOH was added dropwise until the pH dropped to 1 – 2. Then, the mixture was
evaporated, and the residue was dried overnight in a desiccator. Pyridine/Ac O 1:1 (0.5 ml) was added,
2
and the mixture was allowed to react at 1008 for 1 h. After addition of 1 ml of CHCl , the mixture was
3
washed three times with sat. Na CO soln. and H O successively. The org. phase was dried (Na SO ) and
2
3
2
2
4
subjected to GC/MS (Thermo TR-5 MS, 60 m ꢁ 0.25 mm ꢁ 2.5 mm); carrier gas He, flow rate 1 ml/min;
oven temp.: 180 ! 2208 (48/min), 2208 for 2 min, 220 ! 2708 (18/min), and 2708 for 1 min). By
comparison with the retention times of authentic samples (t (d-glucose) 54.88 min, and t (l-glucose)
R
R
5
5.08 min), the configuration of the sugar moieties were determined to be d.
REFERENCES
[
1] ꢀPharmacopoeia of P. R. Chinaꢁ, Editorial Board of Chinese Pharmacopoeia, Chinese Medical
Science and Technology Press, Beijing, 2010, Vol. 1, p. 89.
[2] B. Dinda, D. R. Chowdhury, B. C. Mohanta, Chem. Pharm. Bull. 2009, 57, 765.
[3] R. Kakuda, T. Iijima, Y. Yaoita, K. Machida, M. Kikuchi, J. Nat. Prod. 2001, 64, 1574.
[4] M. Kikuchi, R. Kakuda, M. Kikuchi, Y. Yaoita, J. Nat. Prod. 2005, 68, 751.
[5] R.-W. Jiang, K.-L. Wong, Y.-M. Chan, H.-X. Xu, P. P.-H. But, P.-C. Shaw, Phytochemistry 2005, 66,
2674.
[
[
6] G. Chen, S.-H. Wei, C.-Y. Yu, Biochem. Syst. Ecol. 2009, 37, 766.
7] R.-X. Tan, J.-L. Wolfender, L. X. Zhang, W. G. Ma, N. Fuzzati, A. Marston, K. Hostettmann,
Phytochemistry 1996, 42, 1305.
[
[
8] J.-A. Kim, N. S. Son, J. K. Son, Y. Jahng, H. W. Chang, T. S. Jang, M. K. Na, S.-H. Lee, Arch. Pharm.
Res. 2009, 32, 863.
9] C. Bergeron, A. Marston, R. Gauthier, K. Hostettmann, Phytochemistry 1997, 44, 633.